Virally targeted therapies for EBV-associated malignancies
نویسندگان
چکیده
منابع مشابه
EBV associated malignancies.
Epstein-Barr virus (EBV) infection has been implicated in the aetiopathogenic mechanisms of several neoplastic and non-neoplastic disorders. Although the precise mechanisms of the tumourigenic actions of EBV have not yet been fully elucidated, this virus has been strongly linked to subtypes of Hodgkin’s and non-Hodgkin’s lymphomas (especially Burkitt’s lymphoma), HIV/AIDS lymphomas, nasopharyng...
متن کاملMolecular-Targeted Therapies for Hematologic Malignancies
© 2012 Kevin D. Bunting et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License ( http://creativecommons.org/licenses/by/3.0/), which permits making multiple copies, distribution, public display, and publicly performance, distribution of derivative works, provided the original work is properly cited. This license requires credit...
متن کاملTargeted Therapies in Adult B-Cell Malignancies
B-lymphocytes are programmed for the production of immunoglobulin (Ig) after antigen presentation, in the context of T-lymphocyte control within lymphoid organs. During this differentiation/activation process, B-lymphocytes exhibit different restricted or common surface markers, activation of cellular pathways that regulate cell cycle, metabolism, proteasome activity, and protein synthesis. All...
متن کاملEBV-Associated Cancer and Autoimmunity: Searching for Therapies
Epstein-Barr virus (EBV) infects B-, T-, and NK cells and has been associated not only with a wide range of lymphoid malignancies but also with autoimmune diseases such as lupus erythematosus, rheumatoid arthritis and, in particular, multiple sclerosis. Hence, effective immunotherapeutic approaches to eradicate EBV infection might overthrow cancer and autoimmunity incidence. However, currently ...
متن کاملDevelopment of Molecularly Targeted Therapies to Treat Pediatric Malignancies
Drugs and biologics developed to treat children with cancer have been historically developed in adults for adult indications. Although leading to many useful drugs and biologics to treat pediatric cancer, future development of molecularly targeted therapies (MTTs) should be directed toward pediatric tumors more specifically to maximize antitumor efficacy while minimizing acute morbidity and lon...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncogene
سال: 2003
ISSN: 0950-9232,1476-5594
DOI: 10.1038/sj.onc.1206548